IRMD
IRADIMED CORP
Latest Form 4:Sale$285KbyScharen-Guivel Hilda Frederique (Director) · filed Jun 4, 2026
IRADIMED CORP (IRMD) has 50 SEC Form 4 filings (147 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jun 23, 2026.
The most active filer is CEO, President, Chairman Susi Roger E. with 45 filings. Insiders have net sold $12.2M over the trailing 6 months.
- Industry:Medical - Devices
- CEO:Roger E. Susi
- Employees:160
- HQ:Winter Springs, FL, US
- IPO:2014-07-16
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$21.3M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$1.1B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Scharen-Guivel Hilda FrederiqueFirst filing | Director | Sale | 3,000 | $285K | Jun 4 | SEC ↗ |
| CEO, President, Chairman | Sale | 2,500 | $227K | Jun 2 | SEC ↗ | |
| CEO, President, Chairman | Sale | 5,000 | $461K | May 28 | SEC ↗ | |
| CEO, President, Chairman | Sale | 2,500 | $230K | May 28 | SEC ↗ | |
| CEO, President, Chairman | Sale | 5,000 | $438K | May 20 | SEC ↗ | |
| CEO, President, Chairman | Sale | 2,500 | $220K | May 20 | SEC ↗ | |
| CEO, President, Chairman | Sale | 3,089 | $261K | May 13 | SEC ↗ | |
| CEO, President, Chairman | Sale | 4,411 | $370K | May 13 | SEC ↗ | |
| CEO, President, Chairman | Sale | 3,750 | $321K | May 6 | SEC ↗ | |
| CEO, President, Chairman | Sale | 3,750 | $322K | May 6 | SEC ↗ | |
| CEO, President, Chairman | Sale | 3,750 | $334K | Apr 30 | SEC ↗ | |
| CEO, President, Chairman | Sale | 3,750 | $323K | Apr 30 | SEC ↗ | |
| CEO, President, Chairman | Sale | 5,000 | $467K | Apr 22 | SEC ↗ | |
| CEO, President, Chairman | Sale | 2,500 | $227K | Apr 22 | SEC ↗ | |
| CEO, President, Chairman | Sale | 5,000 | $463K | Apr 15 | SEC ↗ | |
| CEO, President, Chairman | Sale | 2,500 | $235K | Apr 15 | SEC ↗ | |
| CEO, President, Chairman | Sale | 5,000 | $480K | Apr 7 | SEC ↗ | |
| CEO, President, Chairman | Sale | 2,500 | $237K | Apr 7 | SEC ↗ | |
| CEO, President, Chairman | Sale | 7,500 | $713K | Apr 1 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 5,000 | $502K | Mar 25 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 2,500 | $251K | Mar 25 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 5,000 | $507K | Mar 18 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 2,500 | $256K | Mar 18 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 5,000 | $500K | Mar 10 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 2,500 | $250K | Mar 10 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 7,500 | $738K | Mar 9 | SEC ↗ | |
ALLEN MONTY KFirst filing | Director | Sale | 1,000 | $100K | Feb 13 | SEC ↗ |
| CEO, PRESIDENT, CHAIRMAN | Sale | 5,000 | $503K | Jan 27 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 5,000 | $509K | Jan 21 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 5,000 | $487K | Jan 13 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 5,000 | $488K | Jan 6 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 5,000 | $488K | Dec 30 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 5,000 | $484K | Dec 22 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 5,000 | $484K | Dec 17 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 15,000 | $1.5M | Dec 12 | SEC ↗ | |
| Director | Sale | 3,000 | $290K | Dec 10 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 5,000 | $477K | Dec 9 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 5,000 | $464K | Dec 2 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 5,000 | $452K | Nov 24 | SEC ↗ | |
| Director | Sale | 3,000 | $265K | Nov 21 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 5,000 | $428K | Nov 19 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 5,000 | $426K | Nov 12 | SEC ↗ | |
GLENN JOHNFirst filing | CHIEF FINANCIAL OFFICER | Sale | 10,651 | $900K | Nov 12 | SEC ↗ |
| CEO, PRESIDENT, CHAIRMAN | Sale | 5,000 | $413K | Nov 4 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 5,000 | $388K | Oct 29 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 5,000 | $374K | Oct 22 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 5,000 | $363K | Oct 14 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 5,000 | $359K | Oct 7 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 5,000 | $351K | Oct 2 | SEC ↗ | |
| CEO, PRESIDENT, CHAIRMAN | Sale | 5,000 | $356K | Sep 24 | SEC ↗ | |
Susi Roger E.First filing | CEO, PRESIDENT, CHAIRMAN | Sale | 5,000 | $356K | Sep 18 | SEC ↗ |
Related companies
IRADIMED CORP is in the Healthcare sector.